Xylocaine 2% Inj, 10ml

Manufacturer FRESENIUS KABI Active Ingredient Lidocaine Injection Solution (Anesthetic)(LYE doe kane) Pronunciation LYE-doe-kane
It is used to numb an area before a procedure.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Local Anesthetic; Antiarrhythmic (Class IB)
đŸ§Ŧ
Pharmacologic Class
Voltage-gated sodium channel blocker
🤰
Pregnancy Category
B
✅
FDA Approved
Jan 1970
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Lidocaine is a medicine used to numb a part of your body to prevent pain during medical procedures, like stitches or minor surgery. It works by temporarily blocking nerve signals in the area where it's injected.
📋

How to Use This Medicine

To use this medication correctly, follow your doctor's instructions and read all accompanying information carefully. Take this medication exactly as directed, and be sure to follow all instructions provided. This medication is administered via injection.

If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage method.

If you miss a dose, contact your doctor immediately to receive guidance on the appropriate course of action.
💡

Lifestyle & Tips

  • Avoid touching or disturbing the numb area until sensation returns to prevent accidental injury.
  • Follow post-procedure instructions carefully, especially regarding wound care or activity restrictions.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Highly variable, dependent on procedure, site, and concentration. For infiltration anesthesia, typically 0.5% to 1% solution.

Condition-Specific Dosing:

infiltration_anesthesia: Up to 4.5 mg/kg (not to exceed 300 mg) without epinephrine; up to 7 mg/kg (not to exceed 500 mg) with epinephrine.
peripheral_nerve_block: 50-300 mg (e.g., 5-30 mL of 1% solution or 2.5-15 mL of 2% solution).
epidural_anesthesia: 250-300 mg (e.g., 12.5-15 mL of 2% solution).
intravenous_antiarrhythmic: Initial bolus 1-1.5 mg/kg, followed by continuous infusion 1-4 mg/min (for cardiac indications, not typical for local anesthetic injection product).
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established for routine use; extreme caution and reduced doses if used (max 2-4 mg/kg).
Infant: Max 4.5 mg/kg (without epinephrine) or 7 mg/kg (with epinephrine) for local infiltration/nerve block.
Child: Max 4.5 mg/kg (without epinephrine) or 7 mg/kg (with epinephrine) for local infiltration/nerve block.
Adolescent: Max 4.5 mg/kg (without epinephrine) or 7 mg/kg (with epinephrine) for local infiltration/nerve block.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific adjustment typically required for single dose local anesthesia.
Moderate: No specific adjustment typically required for single dose local anesthesia.
Severe: Caution advised; consider reduced doses for repeated or large volume administration due to potential for accumulation of metabolites.
Dialysis: Lidocaine is not significantly dialyzable. Caution with repeated doses.

Hepatic Impairment:

Mild: Caution advised; consider reduced doses.
Moderate: Reduced doses (e.g., 50% of normal dose) and careful monitoring recommended due to impaired metabolism.
Severe: Significantly reduced doses (e.g., 50-75% reduction) and careful monitoring recommended due to impaired metabolism and increased risk of toxicity.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Lidocaine stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses, thereby effecting local anesthetic action. It blocks voltage-gated sodium channels in the neuronal cell membrane, preventing the influx of sodium ions and thus inhibiting depolarization and nerve impulse propagation.
📊

Pharmacokinetics

Absorption:

Bioavailability: Variable, dependent on site of administration, dose, and presence of vasoconstrictor (e.g., epinephrine). Systemic absorption occurs from all sites of administration.
Tmax: Variable, typically 5-15 minutes for infiltration, longer for nerve blocks.
FoodEffect: Not applicable for injectable formulation.

Distribution:

Vd: 0.7-2.7 L/kg (average 1.1 L/kg)
ProteinBinding: 60-80% (primarily to alpha-1-acid glycoprotein and albumin)
CnssPenetration: Yes, readily crosses the blood-brain barrier and placenta.

Elimination:

HalfLife: 1.5-2 hours (prolonged in hepatic impairment, heart failure, and in neonates)
Clearance: Approximately 10 mL/min/kg
ExcretionRoute: Renal (primarily as metabolites)
Unchanged: Less than 10% (approximately 3% of unchanged drug and 4% of MEGX are excreted in urine).
âąī¸

Pharmacodynamics

OnsetOfAction: Rapid (2-5 minutes for infiltration, 5-15 minutes for nerve blocks)
PeakEffect: Variable, typically within 10-30 minutes.
DurationOfAction: 30-60 minutes (without epinephrine); 60-120 minutes (with epinephrine).

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical attention immediately:

Allergic Reaction: Rash, hives, itching, red, swollen, blistered, or peeling skin with or without fever, wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat.
Methemoglobinemia: A blue or gray color of the lips, nails, or skin, irregular heartbeat, seizures, severe dizziness or fainting, severe headache, excessive sleepiness, feeling tired or weak, or shortness of breath. This rare condition can be life-threatening if left untreated.
Acidosis (Too Much Acid in the Blood): Confusion, rapid breathing, rapid heartbeat, irregular heartbeat, severe stomach pain, nausea, vomiting, excessive sleepiness, shortness of breath, or feeling very tired or weak.
Respiratory Problems: Trouble breathing, slow breathing, or shallow breathing.
Neurological Symptoms: Feeling lightheaded, sleepy, confused, or having blurred vision.
Cardiovascular Symptoms: Slow heartbeat.
Other Severe Symptoms: Feeling nervous and excitable, trouble speaking, burning, numbness, or tingling sensations, restlessness, anxiety, changes in vision, ringing in the ears, dizziness or fainting, severe headache, twitching, shakiness, seizures, feeling hot or cold, metallic taste, chest pain, or mood changes.

Additional Side Effects of Spinal Injection:

If you receive this medication via spinal injection, you may experience:

Erectile dysfunction
Loss of mobility
Loss of bowel or bladder control
* Urination difficulties

Other Possible Side Effects:

Like all medications, this drug can cause side effects, although many people may not experience any or may only have mild symptoms. If you have any side effects that bother you or do not go away, contact your doctor for advice.

Reporting Side Effects:

You can report any side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch. If you have questions about side effects, consult your doctor for medical advice.
🚨

Seek Immediate Medical Attention If You Experience:

  • Dizziness or lightheadedness
  • Ringing in the ears (tinnitus)
  • Numbness or tingling around the mouth
  • Unusual taste in the mouth (metallic taste)
  • Blurred vision
  • Tremors or muscle twitching
  • Feeling unusually sleepy or confused
  • Slow or irregular heartbeat
  • Difficulty breathing
  • Any signs of an allergic reaction (rash, itching, swelling, severe dizziness, trouble breathing)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

To ensure safe treatment, inform your doctor of the following:

Any allergies you have to this medication, its components, or other substances, including foods and drugs. Describe the allergic reaction you experienced, including any symptoms.
If you are scheduled to receive this medication via spinal injection, notify your doctor if you have:
+ Heart block
+ Severe bleeding
+ Severe infection
+ An infection at the injection site

It is essential to disclose all your medications, including prescription and over-the-counter drugs, natural products, and vitamins, as well as any health problems you have. This will help your doctor and pharmacist determine if it is safe to take this medication with your other treatments. Do not start, stop, or adjust the dosage of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

Important Warnings and Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Risk of Methemoglobinemia
A severe blood disorder called methemoglobinemia has been associated with drugs like this one. Your risk may be increased if you have:
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency
- Heart problems
- Lung problems
- Are taking certain other medications
- Are an infant younger than 6 months of age
If you have a history of methemoglobinemia, notify your doctor.

Sulfite Allergy
If you are allergic to sulfites, consult with your doctor, as some products may contain sulfites.

Post-Treatment Precautions
Avoid driving and other activities that require alertness until the effects of this medication have worn off and you feel fully awake. If you are discharged before the numbness has resolved, take precautions to protect the treated area from injury until sensation returns.

Special Considerations
- If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.
- If the patient is a child, use this medication with caution, as the risk of certain side effects may be higher in children.
- If you are pregnant, plan to become pregnant, or are breastfeeding, discuss the benefits and risks with your doctor.

Spinal Injection
If this medication is administered into the spine, it may cause temporary loss of feeling and motor function in the lower half of your body. Do not attempt to get out of bed or perform other activities until normal feeling and motor function have returned.

Mouth and Dental Procedures
Do not eat while your mouth feels numb, as you may inadvertently bite your tongue.
🆘

Overdose Information

Overdose Symptoms:

  • Severe dizziness or lightheadedness
  • Confusion
  • Slurred speech
  • Tremors or muscle twitching
  • Seizures
  • Slow or irregular heartbeat
  • Low blood pressure
  • Difficulty breathing or stopping breathing
  • Loss of consciousness
  • Cardiac arrest

What to Do:

If you experience any severe symptoms after receiving lidocaine, seek immediate medical attention. Call emergency services (e.g., 911 in the US) or your local poison control center (e.g., 1-800-222-1222 in the US).

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Not typically contraindicated for local use, but caution with severe heart block (for IV use).
🔴

Major Interactions

  • Antiarrhythmics (e.g., Class I antiarrhythmics like mexiletine, tocainide): Increased risk of cardiac depression and CNS toxicity.
  • Beta-blockers (e.g., propranolol, metoprolol): May decrease hepatic blood flow, reducing lidocaine clearance and increasing toxicity risk.
  • Cimetidine: Inhibits lidocaine metabolism, increasing plasma levels and toxicity risk.
  • Succinylcholine: May prolong neuromuscular blockade.
🟡

Moderate Interactions

  • Other local anesthetics: Additive systemic toxicity.
  • CYP1A2/CYP3A4 inhibitors (e.g., macrolide antibiotics, azole antifungals, protease inhibitors): May increase lidocaine levels.
  • CYP1A2/CYP3A4 inducers (e.g., rifampin, phenytoin, carbamazepine): May decrease lidocaine levels.
  • Phenytoin: May increase lidocaine metabolism; also, additive cardiac effects.
  • Skeletal muscle relaxants: May enhance or prolong effects.
đŸŸĸ

Minor Interactions

  • Not specifically identified for minor interactions with significant clinical impact for single-dose local anesthesia.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Allergy history

Rationale: To identify hypersensitivity reactions to lidocaine or other amide-type local anesthetics.

Timing: Prior to administration

Vital signs (heart rate, blood pressure, respiratory rate)

Rationale: To establish baseline and identify pre-existing cardiovascular or respiratory compromise.

Timing: Prior to administration

Assessment of injection site

Rationale: To ensure appropriate site selection and identify any contraindications (e.g., infection).

Timing: Prior to administration

📊

Routine Monitoring

Vital signs (heart rate, blood pressure, respiratory rate)

Frequency: During and immediately after administration, then as clinically indicated.

Target: Within patient's normal physiological range.

Action Threshold: Significant deviations (e.g., bradycardia, hypotension, respiratory depression) warrant immediate intervention.

Signs and symptoms of systemic toxicity (CNS and cardiovascular)

Frequency: Continuously during and for at least 30 minutes after administration.

Target: Absence of symptoms.

Action Threshold: Any signs of CNS (e.g., dizziness, tinnitus, perioral numbness, seizures) or cardiovascular (e.g., bradycardia, hypotension, arrhythmias) toxicity require immediate cessation of administration and supportive care.

Effectiveness of anesthesia

Frequency: Periodically after administration.

Target: Adequate pain control/numbness in the target area.

Action Threshold: Inadequate anesthesia may require re-dosing or alternative strategies.

đŸ‘ī¸

Symptom Monitoring

  • Lightheadedness
  • Dizziness
  • Tinnitus
  • Perioral numbness
  • Metallic taste
  • Blurred vision
  • Tremors
  • Muscle twitching
  • Seizures
  • Drowsiness
  • Unconsciousness
  • Respiratory depression/arrest
  • Bradycardia
  • Hypotension
  • Cardiac arrhythmias
  • Cardiac arrest

Special Patient Groups

🤰

Pregnancy

Lidocaine is classified as Pregnancy Category B. Studies in animals have not shown harm to the fetus, and there are no adequate and well-controlled studies in pregnant women. It is generally considered safe for use during pregnancy when clinically indicated and administered at appropriate doses.

Trimester-Specific Risks:

First Trimester: Generally considered low risk; use only if clearly needed.
Second Trimester: Generally considered low risk; use only if clearly needed.
Third Trimester: Generally considered low risk; use only if clearly needed. May cross the placenta and affect the fetus, but adverse effects are rare with appropriate dosing.
🤱

Lactation

Lidocaine is excreted into breast milk in small amounts. The amount ingested by the infant is typically very low and unlikely to cause adverse effects. It is considered compatible with breastfeeding (Lactation Risk Category L2).

Infant Risk: Low risk of adverse effects to the breastfed infant. Monitor infant for drowsiness or feeding difficulties, though these are rare.
đŸ‘ļ

Pediatric Use

Pediatric patients, especially infants and young children, are more susceptible to systemic toxicity due to differences in metabolism, distribution, and body surface area to weight ratio. Dosing must be carefully calculated on a mg/kg basis, and the lowest effective dose should be used. Close monitoring for signs of toxicity is crucial.

👴

Geriatric Use

Elderly patients may be more susceptible to the systemic effects of lidocaine due to age-related decreases in hepatic blood flow, renal function, and plasma protein binding. Reduced doses and careful monitoring are recommended to minimize the risk of toxicity.

Clinical Information

💎

Clinical Pearls

  • Always aspirate prior to injection to ensure the needle is not in a blood vessel, which can lead to rapid systemic absorption and toxicity.
  • Use the lowest effective concentration and volume to achieve the desired anesthetic effect.
  • The addition of epinephrine (vasoconstrictor) prolongs the duration of action and reduces systemic absorption, allowing for higher total doses while minimizing systemic toxicity, but should be avoided in areas with end-arterial circulation (e.g., fingers, toes, nose, penis, ears) due to risk of ischemia.
  • Monitor patients closely for signs of systemic toxicity (CNS and cardiovascular) during and after administration, especially with large volumes or highly vascular injection sites.
  • Be prepared with resuscitation equipment and medications (e.g., lipid emulsion for severe systemic toxicity) when administering large doses or in high-risk patients.
  • Lidocaine is an amide-type local anesthetic; patients with a history of allergy to ester-type local anesthetics (e.g., procaine) may tolerate lidocaine, but cross-reactivity is rare.
🔄

Alternative Therapies

  • Bupivacaine (longer acting amide local anesthetic)
  • Ropivacaine (amide local anesthetic, less cardiotoxic than bupivacaine)
  • Mepivacaine (intermediate acting amide local anesthetic)
  • Procaine (ester local anesthetic, shorter acting)
  • Chloroprocaine (ester local anesthetic, very short acting)
  • Topical anesthetics (e.g., lidocaine cream, patch, spray for superficial anesthesia)
💰

Cost & Coverage

Average Cost: Varies widely based on concentration, volume, and manufacturer. per 10ml vial
Generic Available: Yes
Insurance Coverage: Generally covered by most medical insurance plans when administered in a clinical setting for a medical procedure.
📚

General Drug Facts

If your symptoms or health problems persist or worsen, it is essential to contact your doctor for further guidance. To ensure safe use, do not share your medication with others, and never take someone else's medication. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion. Dispose of unused or expired medications properly; do not flush them down the toilet or pour them down the drain unless instructed to do so by a healthcare professional or pharmacist. If you are unsure about the proper disposal method, consult your pharmacist, as they may be aware of drug take-back programs in your area. Additionally, some medications may come with a separate patient information leaflet; check with your pharmacist for more information. If you have any questions or concerns about your medication, discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately contact your local poison control center or seek medical attention. Be prepared to provide information about the medication taken, the amount, and the time it occurred to ensure prompt and effective treatment.